Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Diabetes Health Center

Font Size

Drug Helps Lower Blood Sugar

Study: Injectable Drug, Called Byetta, May Lower High Blood Sugar in Patients Taking Other Diabetes Drugs
WebMD Health News
Reviewed by Louise Chang, MD

April 2, 2007 -- The injectable diabetes drug Byetta may lower poorly controlled blood sugar in patients with type 2 diabetes, a new study shows.

However, the study was "much too small and much too short," states an editorial published with the study in the Annals of Internal Medicine.

The study included 233 overweight or obese adults with type 2 diabetes in the U.S., Canada, and Spain.

When the study started, the patients were already taking the diabetes drugs Actos or Avandia. Some were also taking the diabetes drug metformin.

However, the patients' blood sugar levels were still too high, according to hemoglobin A1c tests, which show blood sugar control over the previous six to 12 weeks.

Diabetes Drug Study

The researchers included Bernard Zinman, MD, of Mount Sinai Hospital in Toronto. They randomly split the patients into two groups.

Patients in one group were assigned to give themselves two daily injections of Byetta for 16 weeks in addition to the diabetes drugs they were already taking.

For comparison, patients in the other group gave themselves two daily injections of an inactive liquid (placebo) for 16 weeks, in addition to their other diabetes drugs.

None of the patients knew whether they were giving themselves shots of Byetta or the placebo.

At the end of the 16-week study, the patients took hemoglobin A1c tests

Study's Results

During the study, the patients taking Byetta lowered their average hemoglobin A1c level by almost 1 point.

That brought their average hemoglobin A1c level near the upper limit recommended for people with type 2 diabetes.

The Byetta group also lost about 3 pounds during the study, even though the researchers hadn't asked patients in either group to diet, exercise, or make other lifestyle changes.

In comparison, the placebo group didn't improve their average hemoglobin A1c level and didn't change weight in the study.

Today on WebMD

Diabetic tools
Symptoms, diagnosis, treatment, and more.
woman flexing muscles
10 strength training exercises.
Blood sugar test
12 practical tips.
Tom Hanks
Stars living with type 1 or type 2.
kenneth fujioka, md
Can Vinegar Treat Diabetes
Middle aged person
jennie brand miller

Prediabetes How to Prevent Type 2 Diabetes
type 2 diabetes
food fitness planner